Reneo Pharmaceuticals
RPHM
$1.60
Share price
-0.31%
Change (1 day)
-76.57%
Change (1 year)
Categories
EPS for Reneo Pharmaceuticals (RPHM)
EPS in 2023 (TTM): -$2.34
According to Reneo Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$2.34. In 2022 the company made an earnings per share (EPS) of -$2.12 a decrease over its 2021 EPS that were of -$1.68.
EPS history for Reneo Pharmaceuticals from 2020 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$2.34 | 10.38% |
| 2022 | -$2.12 | 26.35% |
| 2021 | -$1.68 | -14.16% |
| 2020 | -$1.95 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$2.18 | -6.84% | 🇺🇸 USA |